top of page
HOME
COMPANY
OVER VIEW
HISTORY
CI
LOCATION
BUSINESS
DUOLAC
DUOLAB
LAB2PRO (OEM/ODM)
GLOBAL PRESENCE
TECHNOLOGY
UNIQUE DUAL COATING
TOP QUALITY GRAS STRAINS
GENETIC FORMULATION
IN-HOUSE FERMENTATION
PROBIOTICS MANUFACTURING
GLOBAL QUALITY MANAGEMENT
INNOVATION
R&D PIPELINE
R&D CENTER
IR
NEWS
CONTACT
Public Relations
NEWS
All Posts
Search
Portfolio of Probiotic Ingredients from Cell Biotech Co. Ltd. achieves GRAS “No Objection” from U.S. FDA
Mar 14, 2024
Probiotic brand Duolac makes foray into pet market
May 12, 2023
Probiotic R&D opportunities: Duolac singles out infant, ageing, oral, liver health potential
Feb 21, 2022
Cell Biotech acquire a European patent for anticancer protein P8 originated from Lactobacillus rhamnosus
Apr 6, 2021
1
2
3
4
5
bottom of page
